Updated July 2026 · 10 min read

Norepinephrine vs Epinephrine vs Phenylephrine for ICU Nurses 2026

Three drips, three very different personalities. They all raise the blood pressure, but they do it through different receptors, and that decides what happens to the heart rate, the cardiac output, and the tissue that ends up on the receiving end. Knowing which pressor fits which patient — and why the team reached for one over the others — is core ICU literacy. Here's the picker.

It all comes down to the receptors

Every pressor's behavior is written in which adrenergic receptors it hits. Alpha-1 receptors on blood vessels cause vasoconstriction — that's what raises systemic vascular resistance and blood pressure. Beta-1 receptors on the heart increase contractility and heart rate. Beta-2 receptors cause some vasodilation and bronchodilation. The three drugs here differ almost entirely in how much of each they stimulate.

Norepinephrine: the default

Norepinephrine (Levophed) is the first-line vasopressor for septic shock and most other distributive and hypotensive shock states, and for good reason. It's a strong alpha-1 vasoconstrictor with just enough beta-1 activity to support the heart, so it raises the blood pressure reliably without the runaway tachycardia epinephrine can cause. The Surviving Sepsis guidelines name it first, titrated to a mean arterial pressure of 65. If one pressor is going to be running on your patient, statistically it's this one. See the full norepinephrine guide for titration and monitoring detail.

Epinephrine: the powerhouse

Epinephrine hits everything — potent alpha-1, beta-1, and beta-2. That makes it the strongest all-around agent: it vasoconstricts, it drives contractility, it raises heart rate, and its beta-2 activity opens the airways. It's first-line for anaphylaxis (where the bronchodilation matters) and for cardiac arrest, and it's a common second agent added when norepinephrine alone isn't holding the pressure in refractory shock. The cost of all that power: it drives the heart rate up, increases myocardial oxygen demand, and characteristically raises the lactate through beta-2–mediated metabolism — a rise you have to interpret carefully so you don't mistake a drug effect for worsening perfusion. The epinephrine guide covers those nuances.

Phenylephrine: the pure squeezer

Phenylephrine (Neo-Synephrine) is the odd one out: pure alpha-1, no beta at all. It raises the blood pressure by vasoconstriction alone and touches nothing on the heart directly. Because the pressure rises without any beta stimulation, the body's baroreceptor reflex often slows the heart rate — the opposite of epinephrine. That makes phenylephrine the go-to when you need to prop up pressure in a patient who is already too tachycardic to tolerate a beta agonist, such as someone in atrial fibrillation with rapid ventricular response, or during a brief procedural drop in pressure. Its downside is the flip side of its strength: with no inotropic support and a reflex slowing of the rate, cardiac output can actually fall, so it's a poor choice when the problem is a weak pump rather than a leaky vasculature. The phenylephrine guide has the full picture.

How the team picks

The logic usually runs like this. For septic or most distributive shock, norepinephrine is first — broad, reliable, rate-neutral. If the pressure won't hold, epinephrine (or vasopressin) is added; epinephrine is also the default when contractility itself is failing or when anaphylaxis or arrest is in play. Phenylephrine is reserved for the specific situation where you want vasoconstriction without any beta effect — classically a tachyarrhythmic patient whose heart rate you don't want to push, or a short bridge during a procedure. Think of it as: norepinephrine for almost everyone, epinephrine when you need more horsepower or bronchodilation, phenylephrine when the heart rate is the problem.

What the nurse watches on any of them

All three demand the same vigilance: an arterial line or frequent cuff pressures titrated to a MAP target (usually 65), continuous telemetry for arrhythmias and rate changes, and ideally central access — extravasation of a potent vasoconstrictor into peripheral tissue causes ischemic injury, and phentolamine is the antidote to know. Watch the perfusion endpoints, not just the number: urine output, mentation, lactate trend, and skin temperature tell you whether the pressure you're generating is actually reaching tissue. None of these drugs provides sedation or analgesia, and a patient sick enough to need them usually needs those addressed separately. Compare the pure-inotrope options in our milrinone vs dobutamine guide when the issue is pump failure rather than vascular tone.

Related: Norepinephrine (Levophed) · Epinephrine · Phenylephrine · Vasopressor overview